Almond Table of California changes its tale following NewsTarget article Following NaturalNews’s original story about the Almond Board of California launching plans to falsely label pasteurized almonds because raw, the business changed its tale in emails being sent to consumers, and today claims the rules have nothing to do with the real labeling of almonds. On April 4th When NaturalNews initial contacted the Almond Panel of California, a letter was received by us from the organization that stated, As is the full case with many other foods treated for safety, raw almonds which have been pasteurized do not differ in any significant way from untreated raw almonds, and they are still marketed as raw under Food & Medication Administration labeling rules. After our tale ran, the Almond Table changed its response to consumer emails FDA .
The trials were made to support regulatory submissions for linaclotide in both Europe and the U.S. In August 2011, Ironwood and its own U.S. Partner Forest Laboratories, Inc. Submitted a New Drug Application for linaclotide to the U.S. Drug and Food Administration.. Almirall submits linaclotide MAA to EMA for treatment of IBS-C Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. Submitted a Advertising Authorization Application to the European Medicines Agency for linaclotide, a guanylate cyclase type-C agonist, for the treating irritable bowel syndrome with constipation .